ROLE OF PATHOGENS IN DIABETIC FOOT INFECTION AND THE POTENTIAL OF IMMUNOPROTEOMICS AS A DIAGNOSTIC AND PROGNOSTIC TOOL

Main Article Content

Umar Akhtar
 Usama Jabbar
Sama Khaliq
Zainab Khan
M Faisal Javaid
 Shoaib Ahmed
Zahra Jabeen

Keywords

.

Abstract

Introduction: Diabetic foot infection (DFI) stands as a prevalent and debilitating complication of diabetes mellitus, posing significant challenges to patients' quality of life and healthcare systems worldwide.


Objectives: The main objective of the study is to find the role of pathogens in diabetic foot infection (DFI) and the potential of immunoproteomics as a diagnostic and prognostic tool.


Material and methods: This prospective observational study was conducted at Rashid Latif Medical and Dental College, Lahore from June 2021 to November 2021. Data were collected from 550 diabetic patients suffering from DFI. Data were collected through a systematically designed questionnaire which included clinical evaluation, including medical history assessment, physical examination, and wound assessment.


Results: Data were collected from 550 patients from both genders. There were 60% male and 40% female. Mean age of patients was 65.09 ± 8.3 years and the mean duration of diabetes was 11.98 ± 6.51 years. 70% of the patients also suffering from hypertension, 45% Peripheral Neuropathy and 30% from Peripheral Vascular Disease. Staphylococcus aureus, both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains, are the most prevalent pathogens, with MRSA exhibiting a resistance rate of 30%. Enterococcus spp., Escherichia coli, and Pseudomonas aeruginosa are also prevalent, with Escherichia coli showing notable resistance rates of 60% to ciprofloxacin and 40% to gentamicin. Elevated levels of IL-6 and TNF-alpha show positive correlations with wound size (IL-6: r = 0.65, p < 0.001; TNF-alpha: r = 0.55, p = 0.005), tissue depth involvement (IL-6: r = 0.50, p = 0.002; TNF-alpha: r = 0.45, p = 0.015), and amputation rate (IL-6: r = 0.75, p < 0.001; TNF-alpha: r = 0.70, p < 0.001).


Conclusion: It is concluded that the role of pathogens and host immune response in diabetic foot infections (DFI) is important for guiding effective treatment strategies.

Abstract 150 | PDF Downloads 45

References

1. Chai, Wei, et al. "The Profile of Microbiological Pathogens in Diabetic Foot Ulcers." Frontiers in Medicine, vol. 8, 2021, https://doi.org/10.3389/fmed.2021.656467.
2. Barwell ND, Devers MC, Kennon B, Hopkinson HE, McDougall C, Young MJ, et al.. Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract. (2017) 71. 10.1111/ijcp.13006
3. Fabiani S., Fallahi P., Ferrari S. M., Miccoli M., Antonelli A. (2018). Hepatitis C virus infection and development of type 2 diabetes mellitus: systematic review and meta-analysis of the literature. Rev. Endocr. Metab. Disord. 19, 405–420. doi: 10.1007/s11154-017-9440-1
4. Hine J. L., De Lusignan S., Burleigh D., Pathirannehelage S., Mcgovern A., Gatenby P., et al.. (2017). Association between glycaemic control and common infections in people with type 2 diabetes: a cohort study. Diabet. Med. 34, 551–557. doi: 10.1111/dme.13205
5. Klekotka R. B., Mizgała-Izworska E., Drzastwa W., Mazur B. (2018). The role of in the clinical diagnosis of diabetic patients. Postępy Mikrobiol. Advancem. Microbiol. 57, 166–178. doi: 10.21307/PM-2018.57.2.166
6. Kundu J., Bakshi S., Joshi H., Bhadada S. K., Verma I., Sharma S. (2020). Proteomic profiling of peripheral blood mononuclear cells isolated from patients with tuberculosis and diabetes copathogenesis - A pilot study. PLoS One 15:e0233326. doi: 10.1371/journal.pone.0233326
7. Pouget, C., Dunyach-Remy, C., Pantel, A., Schuldiner, S., Sotto, A., & Lavigne, J. P. (2020). Biofilms in diabetic foot ulcers: Significance and clinical relevance. Microorganisms, 8(10), 1580.
8. Shettigar, K., & Murali, T. S. (2020). Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection. European Journal of Clinical Microbiology & Infectious Diseases, 39(12), 2235-2246.
9. Boulton, A. J., Armstrong, D. G., Hardman, M. J., Malone, M., Embil, J. M., Attinger, C. E., ... & Kirsner, R. S. (2020). Diagnosis and management of diabetic foot infections.
10. Macdonald, K. E., Boeckh, S., Stacey, H. J., & Jones, J. D. (2021). The microbiology of diabetic foot infections: a meta-analysis. BMC infectious diseases, 21, 1-10.
11. Guzman, N. A., & Guzman, D. E. (2021). Immunoaffinity capillary electrophoresis in the era of proteoforms, liquid biopsy and preventive medicine: a potential impact in the diagnosis and monitoring of disease progression. Biomolecules, 11(10), 1443.
12. Chen, Z. Z., & Gerszten, R. E. (2020). Metabolomics and proteomics in type 2 diabetes. Circulation research, 126(11), 1613-1627.
13. Ball, B., Langille, M., & Geddes-McAlister, J. (2020). Fun (gi) omics: Advanced and diverse technologies to explore emerging fungal pathogens and define mechanisms of antifungal resistance. MBio, 11(5), 10-1128.
14. Thurlow, L. R., Stephens, A. C., Hurley, K. E., & Richardson, A. R. (2020). Lack of nutritional immunity in diabetic skin infections promotes Staphylococcus aureus virulence. Science advances, 6(46), eabc5569.
15. Moritz, C. P., Paul, S., Stoevesandt, O., Tholance, Y., Camdessanché, J. P., & Antoine, J. C. (2020). Autoantigenomics: holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. Autoimmunity reviews, 19(2), 102450.
16. Taunk, K., Kalita, B., Kale, V., Chanukuppa, V., Naiya, T., Zingde, S. M., & Rapole, S. (2020). The development and clinical applications of proteomics: An Indian perspective. Expert Review of Proteomics, 17(6), 433-451.
17. Fulton, K. M., Baltat, I., & Twine, S. M. (2019). Immunoproteomics methods and techniques. Immunoproteomics: methods and protocols, 25-58.
18. Ceciliani, F., Eckersall, D., Burchmore, R., & Lecchi, C. (2014). Proteomics in veterinary medicine: applications and trends in disease pathogenesis and diagnostics. Veterinary pathology, 51(2), 351-362.
19. Chen, Z. Z., & Gerszten, R. E. (2020). Metabolomics and proteomics in type 2 diabetes. Circulation research, 126(11), 1613-1627.
20. Guzman, N. A., & Guzman, D. E. (2021). Immunoaffinity capillary electrophoresis in the era of proteoforms, liquid biopsy and preventive medicine: a potential impact in the diagnosis and monitoring of disease progression. Biomolecules, 11(10), 1443.
21. Thurlow, L. R., Stephens, A. C., Hurley, K. E., & Richardson, A. R. (2020). Lack of nutritional immunity in diabetic skin infections promotes Staphylococcus aureus virulence. Science advances, 6(46), eabc5569.
22. Moritz, C. P., Paul, S., Stoevesandt, O., Tholance, Y., Camdessanché, J. P., & Antoine, J. C. (2020). Autoantigenomics: holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. Autoimmunity reviews, 19(2), 102450.
23. de Almeida, J. R. F., Jannuzzi, G. P., Kaihami, G. H., Breda, L. C. D., Ferreira, K. S., & de Almeida, S. R. (2018). An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis. Scientific Reports, 8(1), 4192.
24. Taunk, K., Kalita, B., Kale, V., Chanukuppa, V., Naiya, T., Zingde, S. M., & Rapole, S. (2020). The development and clinical applications of proteomics: An Indian perspective. Expert Review of Proteomics, 17(6), 433-451.